Search Results for ''

published presentations and documents on DocSlides.

Sofosbuvir  + Ribavirin to Prevent Post-Transplant HCV Recurrence
Sofosbuvir + Ribavirin to Prevent Post-Transplant HCV Recurrence
by briana-ranney
Sofosbuvir + Ribavirin to Prevent Post-Transplan...
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
Ledipasvir-Sofosbuvir Retreatment with HCV Genotype 1
by danika-pritchard
NIAID Retreatment. Phase . 2a . Treatment. . Exp...
Sofosbuvir-Velpatasvir  in HCV Genotype 1, 2, 4, 5, or 6
Sofosbuvir-Velpatasvir in HCV Genotype 1, 2, 4, 5, or 6
by pasty-toler
ASTRAL-1. Phase 3. . Treatment. . Naïve & ...
Sofosbuvir in HCV-
Sofosbuvir in HCV-
by mitsue-stanley
HIV Coinfection & HCV . GT 1,2,3. PHOTON-1 Tr...
Sofosbuvir + Ribavirin in HCV Genotype 1
Sofosbuvir + Ribavirin in HCV Genotype 1
by pamella-moone
NIH SPARE. Phase . 2. Treatment. . Naïve . (unf...
Sofosbuvir  + Ribavirin in HCV Recurrence
Sofosbuvir + Ribavirin in HCV Recurrence
by williams
Following Liver Transplantation. Phase 2. Charlton...
Sofosbuvir in Genotypes 2 or 3
Sofosbuvir in Genotypes 2 or 3
by giovanna-bartolotta
VALENCE Trial. Phase . 3. Treatment. Naïve and ...
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by jane-oiler
(. Epclusa. ). Prepared by. : H. Nina Kim, MD MS...
Sofosbuvir in
Sofosbuvir in
by giovanna-bartolotta
Genotype . 2. . or 3 . FUSION. Trial. Phase . ...
Ledipasvir-Sofosbuvir (
Ledipasvir-Sofosbuvir (
by lindy-dunigan
Harvoni. ). Prepared by: . David H. Spach, MD and...
Sofosbuvir + Peginterferon + Ribavirin in Genotype 2
Sofosbuvir + Peginterferon + Ribavirin in Genotype 2
by debby-jeon
. or 3 . LONESTAR-2. Phase 2. Treatment. . Exp...
Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir
by trish-goza
in Genotype 3. ASTRAL-3. Phase 3. . Treatment. ...
Sofosbuvir-Velpatasvir  in Genotype 2
Sofosbuvir-Velpatasvir in Genotype 2
by stefany-barnette
ASTRAL-2*. Phase 3. . Treatment. . Naïve &...
Ledipasvir-Sofosbuvir   RBV in HCV GT 1,4 and Advanced Liver Disease
Ledipasvir-Sofosbuvir RBV in HCV GT 1,4 and Advanced Liver Disease
by alida-meadow
SOLAR-1 (Cohorts A and B). Phase . 2 . Treatment ...
Daclatasvir  + Sofosbuvir + RBV in GT3
Daclatasvir + Sofosbuvir + RBV in GT3
by sophia2
. with Advanced Liver Disease. ALLY-3+ Study. Phas...
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
Sofosbuvir-Velpatasvir in Decompensated HCV Cirrhosis
by ahmir
ASTRAL-4. Source: Curry MP, et al. N Engl J Med. 2...
Ledipasvir-Sofosbuvir ( Harvoni
Ledipasvir-Sofosbuvir ( Harvoni
by sherrill-nordquist
). Slide deck prepared . by: . David H. Spach, MD...
Ledipasvir-Sofosbuvir in GT-1
Ledipasvir-Sofosbuvir in GT-1
by faustina-dinatale
. and HIV Coinfection. NIAID ERADICATE Trial. Ph...
Sofosbuvir
Sofosbuvir
by luanne-stotts
+ Ribavirin to Prevent Post-Transplant HCV Recur...
Daclatasvir
Daclatasvir
by tatyana-admore
. + . Sofosbuvir. in Genotype . 3. ALLY-3 Study...
Daclatasvir
Daclatasvir
by giovanna-bartolotta
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
Trent W Nichols
Trent W Nichols
by cheryl-pisano
Hepatitis-2015. Orlando. , USA. July 20 - 22 20...
Newest Drugs for Hepatitis C
Newest Drugs for Hepatitis C
by tawny-fly
Matthew Luu, Yuan Fang (Pearl) Cai, Shiming Sun, ...
2014: HIV, HCV, and  HBV
2014: HIV, HCV, and HBV
by kittie-lecroy
Update. David Spach, MD. Professor of Medicine,...
Andrew I. Aronsohn, MD Associate Professor of Medicine
Andrew I. Aronsohn, MD Associate Professor of Medicine
by alida-meadow
University of Chicago. Chicago, Illinois. Challen...
Daclatasvir
Daclatasvir
by trish-goza
+ Sofosbuvir in HCV GT 1-4 and HIV Coinfection. A...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by trish-goza
IAPAC African Regional Capacity-Building Hub. Bas...
HCV Clinical Management TRAINER(S)
HCV Clinical Management TRAINER(S)
by danika-pritchard
IAPAC African Regional Capacity-Building Hub. Bas...
Chronic hepatitis C: guidelines for screening and
Chronic hepatitis C: guidelines for screening and
by aaron
treatment. Lisa M. Glass, MD. Clinical Lecturer. ...
Sofosbuvir-Velpatasvir-Voxilaprevir
Sofosbuvir-Velpatasvir-Voxilaprevir
by faustina-dinatale
in DAA. -Naïve GT . 1-6 . POLARIS-2. Phase 3. ...
Simeprevir
Simeprevir
by olivia-moreira
. + Sofosbuvir +/- Ribavirin in Genotype 1. COS...
Hepatitis C Imtiaz Alam, M.D.
Hepatitis C Imtiaz Alam, M.D.
by olivia-moreira
Medical Director, Austin Hepatitis Center. 1. Hep...
HIV and HCV Update for the Pharmacist – June 2014
HIV and HCV Update for the Pharmacist – June 2014
by marina-yarberry
John J. . Faragon. , . PharmD. , BCPS, AAHIV-P. R...
Advances in Hepatitis C Identification and Treatment
Advances in Hepatitis C Identification and Treatment
by giovanna-bartolotta
Developed by Camilla S. Graham, MD, BIDMC, 5/5/15...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Daclatasvir in Combination With Sofosbuvir
Daclatasvir in Combination With Sofosbuvir
by mitsue-stanley
With Or Without Ribavirin Is Safe and Efficacious...
Last
Last
by yoshiko-marsland
Updated: . July . 6. , . 2015. Treatment of Hepat...
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
Management of Patients with Chronic Hepatitis C: The Route to Safe and Effective Care
by lois-ondreau
Sameh W. Boktor, MD, MPH. Medical Epidemiologist....
Advances in the Treatment of
Advances in the Treatment of
by danika-pritchard
HCV Genotype 3 and HIV/HCV Coinfection . What's S...
May 3, 2016: Hepatitis  C Kills More Americans than Any Other Infectious
May 3, 2016: Hepatitis C Kills More Americans than Any Other Infectious
by luanne-stotts
Disease. Annual Hepatitis . C-related mortality i...